Significant upside for pharma stock prices, dividends

Pharmaceutical firms' adept handling of patent expirations has boosted investors' opinions of the sector, says Morningstar's Damien Conover.

Jeremy Glaser 8 February, 2012 | 3:00AM
Facebook Twitter LinkedIn

 

 

Jeremy Glaser: For Morningstar, I am Jeremy Glaser. To give us an update on the Big Pharma space, I am here today with Damien Conover; he is our associate director of health care.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free
TAGS
Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
Abbott Laboratories118.95 USD0.13Rating
AstraZeneca PLC ADR53.81 USD0.62Rating
Bayer AG ADR16.47 USD0.86Rating
Eli Lilly and Co195.42 USD0.79Rating
GlaxoSmithKline PLC ADR38.35 USD1.16Rating
Johnson & Johnson168.50 USD0.45Rating
Merck & Co Inc78.41 USD0.81Rating
Pfizer Inc39.58 USD1.00Rating
Roche Holding AG ADR42.13 USD2.08Rating
Sanofi SA ADR51.82 USD1.59Rating

About Author

Jeremy Glaser

Jeremy Glaser  Jeremy Glaser is the Markets Editor for Morningstar.com.

© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies